about
In vivo observation of Langerhans cells by laser confocal microscopy in Thygeson's superficial punctate keratitisBetamethasone dose and formulation for induced lung maturation in fetal sheep.Efficacy of steroid and nonsteroid caudal epidural injections for low back pain and sciatica: a prospective, randomized, double-blind clinical trial.Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model.Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate.Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile.Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects.Comparison of the anti-inflammatory activity and effect on intraocular pressure of fluoromethalone, clobetasone butyrate and betamethasone phosphate eye dropsThe effects of betamethasone derivatives on endotoxin-induced uveitis in ratsTherapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitisLC-MS/MS determination of betamethasone and its phosphate and acetate esters in human plasma after sample stabilizationPharmacokinetics of betamethasone and betamethasone 17-monopropionate in Chinese healthy volunteers after intramuscular injection of betamethasone phosphate/betamethasone dipropionateBreaking the aggregation of the monoclonal antibody bevacizumab (avastin®) by dexamethasone phosphate: insights from molecular modelling and asymmetrical flow field-flow fractionation
P921
Q33489500-E015EA2D-59C6-477C-84FD-723846581D8AQ37463802-037A4F94-DBF1-4F43-AAC2-4D72F02EBD64Q39302319-AEC36750-D47F-41F6-8D2F-6FAB19FC85C8Q39541907-69862238-F5C6-4C21-8429-4F9CE8923C90Q43283927-A0AA1369-5A7F-4FED-A912-4DE985583EBDQ45989949-3375B45B-8301-4FFB-BA68-F65CC91EEFA6Q46108352-C11EA882-D8F6-4BFF-ADA3-442EE670F22EQ46546130-E92B7BA7-E5DE-4AB7-9578-165F365DF6B9Q48270373-34198341-4419-46EE-9096-5A2FD4A07A84Q68938587-A8F25626-EB8B-4F5E-9FC9-AABE88F33A04Q73202576-3295C6F8-6AD2-4480-AAE4-F5C93A95559FQ82995994-90BA8DA2-A428-43ED-8B0B-9EBB48655DCFQ84797149-8452B3DB-E54D-4646-8E7E-D0512C30D5A2Q84906766-5111D428-CC29-478C-9B28-A9CB181E6EE0Q86126079-3FFD8296-EC20-4F50-9F67-13FAC865BB83
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
betamethasone dihydrogen phosphate
@en
type
label
betamethasone dihydrogen phosphate
@en
altLabel
betamethasone 21-phosphate
@en
prefLabel
betamethasone dihydrogen phosphate
@en
P592
P661
P662
P683
P2017
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(= ...... @]1(C(=O)COP(=O)(O)O)O)C)O)F)C
P2067
P231
P232
P233
CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)(O)O)O)C)O)F)C
P234
1S/C22H30FO8P/c1-12-8-16-15-5- ...... ,16-,17-,19-,20-,21-,22-/m0/s1
P235
VQODGRNSFPNSQE-DVTGEIKXSA-N
P2566
100.006.034
P274
C₂₂H₃₀FO₈P
P3117
DTXSID2047224
P592
CHEMBL1201207
P652
YJO1F9W10R